PET/CT in Head-neck Malignancies: The Implications for Personalized Clinical Practice.
PET/CT has been shown to help localize head and neck cancers and provide more accurate staging, post-treatment assessment, and restaging than standard imaging. PET/CT detects synchronous and metachronous cancers and sequelae of therapy and provides prognostic information for each patient. Information provided by PET/CT allows for more individualized therapeutic and surveillance plans for patients with head and neck squamous cell carcinoma.
Department of Radiation Therapy, LAC-USC Medical Center, Keck Medical School of USC, 1983 Marengo Street, D&T Building, 4th Floor 4D334, Los Angeles, CA 90033, USA. Electronic address: wassef@med.usc.edu.
Heidi R
HR
Wassef
Department of Radiation Oncology, Huntsman Cancer Hospital, 1950 Circle of Hope, Room 1570, Salt Lake City, UT 84112, USA.
Nevine
N
Hanna
Department of Radiation Therapy, LAC-USC Medical Center, Keck Medical School of USC, 1983 Marengo Street, D&T Building, 4th Floor 4D334, Los Angeles, CA 90033, USA.
Patrick
P
Colletti
D006257:Head / Q000000981:diagnostic imaging; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging*; D006801:Humans; D009333:Neck / Q000000981:diagnostic imaging; D000072078:Positron Emission Tomography Computed Tomography / Q000379:methods*; D057285:Precision Medicine / Q000379:methods*
FDG; Fluorodeoxyglucose F 18; HNSCC; Head and neck; PET/CT; Positron emission tomography/computer tomography; Squamous cell carcinoma